These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37332530)

  • 1. An external facilitation intervention to increase uptake of an adverse drug event reporting intervention.
    Lau EY; Small SS; Butcher K; Cragg A; Loh GW; Shalansky S; Hohl CM
    Front Health Serv; 2023; 3():1106586. PubMed ID: 37332530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
    Cragg A; Small SS; Lau E; Rowe A; Lau A; Butcher K; Hohl CM
    Drug Saf; 2023 Nov; 46(11):1161-1172. PubMed ID: 37783974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study.
    Lau EY; Cragg A; Small SS; Butcher K; Hohl CM
    JMIR Hum Factors; 2024 Jan; 11():e52495. PubMed ID: 38236629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design.
    Peddie D; Small SS; Badke K; Wickham ME; Bailey C; Chruscicki A; Ackerley C; Balka E; Hohl CM
    JMIR Res Protoc; 2016 Aug; 5(3):e169. PubMed ID: 27538362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China.
    He W; Yao D; Hu Y; Dai H
    Ther Clin Risk Manag; 2018; 14():2139-2147. PubMed ID: 30464487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial.
    Hau JP; Brasher PMA; Cragg A; Small S; Wickham M; Hohl CM
    Trials; 2021 Feb; 22(1):119. PubMed ID: 33546752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Professional, structural and organisational interventions in primary care for reducing medication errors.
    Khalil H; Bell B; Chambers H; Sheikh A; Avery AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003942. PubMed ID: 28977687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing medication errors for adults in hospital settings.
    Ciapponi A; Fernandez Nievas SE; Seijo M; Rodríguez MB; Vietto V; García-Perdomo HA; Virgilio S; Fajreldines AV; Tost J; Rose CJ; Garcia-Elorrio E
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD009985. PubMed ID: 34822165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital admissions caused by adverse drug events: an Australian prospective study.
    Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
    Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.
    Jha AK; Kuperman GJ; Teich JM; Leape L; Shea B; Rittenberg E; Burdick E; Seger DL; Vander Vliet M; Bates DW
    J Am Med Inform Assoc; 1998; 5(3):305-14. PubMed ID: 9609500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration.
    Gustavson AM; Wisdom JP; Kenny ME; Salameh HA; Ackland PE; Clothier B; Noorbaloochi S; Gordon AJ; Hagedorn HJ
    Implement Sci Commun; 2021 Feb; 2(1):20. PubMed ID: 33588952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.
    Roulet L; Asseray N; Dary M; Chiffoleau A; Potel G; Ballereau F
    Int J Clin Pharm; 2012 Dec; 34(6):902-10. PubMed ID: 22923368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency department visits caused by adverse drug events: results of a French survey.
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
    Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement.
    Whitaker R; Hendry M; Aslam R; Booth A; Carter B; Charles JM; Craine N; Tudor Edwards R; Noyes J; Ives Ntambwe L; Pasterfield D; Rycroft-Malone J; Williams N
    Health Technol Assess; 2016 Feb; 20(16):1-214. PubMed ID: 26931051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of peer specialist services in VA primary care: a cluster randomized trial on the impact of external facilitation.
    Chinman M; Goldberg R; Daniels K; Muralidharan A; Smith J; McCarthy S; Medoff D; Peeples A; Kuykendall L; Vineyard N; Li L
    Implement Sci; 2021 Jun; 16(1):60. PubMed ID: 34099004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record.
    Chruscicki A; Badke K; Peddie D; Small S; Balka E; Hohl CM
    Springerplus; 2016; 5(1):1764. PubMed ID: 27795906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.